Thomas Mollick, President and Co-Founder of Rx Development, Establishes Scholarship to Support Emerging Undergraduate Entrepreneurs

Image: https://www.globalnewslines.com/uploads/2025/12/1765835754.jpg

Thomas Mollick

ODESSA, FL - December 18, 2025 - Thomas Mollick, an accomplished healthcare entrepreneur and President of Rx Development, has launched the Thomas Mollick [https://thomasmollick.com/] Scholarship for Entrepreneurs, an annual $1,000 award designed to empower exceptional undergraduate students across the United States who exhibit outstanding potential in entrepreneurship.

The merit-based scholarship will be awarded to one undergraduate student enrolled at an accredited U.S. college or university who best articulates a compelling entrepreneurial vision through a competitive written application process. Candidates are required to submit an original essay of 500-1,000 words detailing their entrepreneurial aspirations, the societal or industry challenge they intend to address, the anticipated impact of their venture, and the personal conviction driving their ambitions.

"True entrepreneurship begins with recognizing unmet needs and possessing the determination to create sustainable solutions," stated Thomas Mollick [https://thomasmollickscholarship.com/]. "Having navigated the resource constraints common to students with big ideas, I am committed to removing financial barriers for the next generation of innovators at a pivotal moment in their journeys."

A graduate of Assumption University with a Bachelor of Arts in Business Management, Mr. Mollick co-founded Rx Development with a focus on advancing innovation within the pharmaceutical and healthcare sectors. The firm has earned industry recognition for its operational rigor, strategic acumen, and unwavering commitment to ethical practices. Headquartered in Odessa, Florida, Mr. Mollick continues to play an active leadership role in regional business and economic-development initiatives.

The Thomas Mollick [https://thomasmollick.org/] Scholarship for Entrepreneurs is open to students from all academic disciplines who demonstrate a clear intent to pursue entrepreneurial endeavors, whether through founding a company, launching a social enterprise, or driving innovation within an existing organization.

Program Timeline and Requirements:

* Application Deadline: September 15, 2026
* Winner Notification and Public Announcement: October 15, 2026
* Award: $1,000 (one-time, non-renewable grant)
* Eligibility: Currently enrolled undergraduate students at accredited U.S. institutions with a demonstrated commitment to entrepreneurship
* Submission: Essays must be submitted in PDF or Microsoft Word format to apply@thomasmollickscholarship.com [mailto:apply@thomasmollickscholarship.com]

An independent selection committee will evaluate submissions based on originality, strength and clarity of vision, depth of passion, and overall writing excellence. The recipient will be notified privately and, with consent, featured on the scholarship's official channels.

This initiative aligns with a broader national priority to cultivate entrepreneurial talent as a catalyst for economic growth, technological progress, and community vitality. Through targeted early-stage investment in promising leaders, Mr. Mollick seeks to accelerate the development of ventures that will define the future commercial landscape.

Complete program details, including the official essay prompt, eligibility criteria, evaluation rubric, and frequently asked questions, are available at www.thomasmollickscholarship.com [http://www.thomasmollickscholarship.com/].
Media Contact
Company Name: Thomas Mollick Scholarship for Entrepreneurs
Contact Person: Thomas Mollick
Email: Send Email [http://www.universalpressrelease.com/?pr=thomas-mollick-president-and-cofounder-of-rx-development-establishes-scholarship-to-support-emerging-undergraduate-entrepreneurs]
City: ODESSA
State: Florida
Country: United States
Website: http://www.thomasmollickscholarship.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.